Search Results | Blood | American Society of Hematology

1-20 of 140

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Clinical Significance of Prolymphocytes in Chinese Patients with Chronic Lymphocytic Leukemia

Lingxiao Xing, Yan Wang, Yi Miao, Huayuan Zhu, Jing Zhang, Li Wang, LEI Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 4694.

DOI: https://doi.org/10.1182/blood-2021-149099

Published: 2021

Journal Articles

Venetoclax Combined with Dose-Adjusted R-EPOCH (VR-DA-EPOCH) As Treatment of Richter's Syndrome: A Real-World Study

Huayuan Zhu, Rui Jiang, Hui Shen, Wei Wu, Yilian Yang, Chen Peng, Jingyan Qiu, Chongyang Ding, Chuanbing Shi, Ruize Chen, Li Wang, Lei Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 4695.

DOI: https://doi.org/10.1182/blood-2021-152483

Published: 2021

Journal Articles

BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia：a Single Arm Real-World Study

Huayuan Zhu, Wei Wu, Yeqin Sha, Ze Jin, Yilian Yang, Jingyan Qiu, Chongyang Ding, Zhen Wang, Chuanbing Shi, Chen Peng, Hongling Mi, Ruize Chen, Li Wang, Lei Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 4697.

DOI: https://doi.org/10.1182/blood-2021-152147

Published: 2021

Journal Articles

The Decrease of Anti-CD3 Antibody Concentration Improved the Cytotoxicity of Chimeric Antigen Receptor (CAR) T Cells in the Treatment of Chronic Lymphoblastic Leukemia (CLL)

Sanmei Wang, Yilian Yang, Yu Zhu, Lei Fan, Michael Schmitt, Maria Luisa Schubert, Jianyong Li

Blood (2021) 138 (Supplement 1): 4792.

DOI: https://doi.org/10.1182/blood-2021-150661

Published: 2021

Journal Articles

Single-Cell Sequencing Technology Reveals the Heterogeneity of the Immune Microenvironment and Key Molecules of Drug Resistance in Angioimmunoblastic T-Cell Lymphoma

Hui Jin, Lei Fan, Xueying Lu, Lei Cao, Zijuan Wu, Luqiao Wang, Huayuan Zhu, Jianyong Li

Blood (2021) 138 (Supplement 1): 1322.

DOI: https://doi.org/10.1182/blood-2021-152354

Published: 2021

Journal Articles

Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 1830.

DOI: https://doi.org/10.1182/blood-2021-150037

Published: 2021

Journal Articles

Single-Cell RNA Sequencing Suggests Novel Drivers of Chronic Lymphocytic Leukemia Patients with Ibrutinib Resistance

Hui Jin, Zijuan Wu, Huayuan Zhu, Lei Fan, Luqiao Wang, Danling Gu, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 1539.

DOI: https://doi.org/10.1182/blood-2021-149963

Published: 2021

Journal Articles

The Prognosis of Intermediate- and High-Risk Young AML Patients Who Did Not Receive Allo-HSCT Treated with Intensive Chemotherapy Is Not Superior to That of Elderly AML Patients Treated with the D-CAG Regimen

Ming Hong, Qian Sun, Wenjie Liu, Han Zhu, Yu Zhu, Jianyong Li, Sixuan Qian

Blood (2021) 138 (Supplement 1): 1228.

DOI: https://doi.org/10.1182/blood-2021-149060

Published: 2021

Journal Articles

Investigation of the Heterogeneity Evolution and Drug Resistance Mechanism of Diffuse Large B-Cell Lymphoma Under the Treatment of a Novel HDAC Inhibitor LAQ824

Hui Jin, Luqiao Wang, Lei Fan, Zijuan Wu, Xueying Lu, Danling Gu, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 3988.

DOI: https://doi.org/10.1182/blood-2021-152006

Published: 2021

Journal Articles

Novel Oncogenic Non-Coding RNA：circRIC8B Regulates Lipid Metabolism Via Mir-199b-5p /LPL Axis in Chronic Lymphocytic Leukemia

Hui Jin, Zijuan Wu, Lei Fan, Luqiao Wang, Xueying Lu, Danling Gu, Lei Cao, Jianyong Li

Blood (2021) 138 (Supplement 1): 3712.

DOI: https://doi.org/10.1182/blood-2021-151866

Published: 2021

Journal Articles

Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial

Wei Xu, Yi Xia, Li Wang, Kaiyang Ding, Huayuan Zhu, Maogui Hu, Hua Yin, Jiazhu Wu, Haorui Shen, Jin-Hua Liang, Jianyong Li

Blood (2021) 138 (Supplement 1): 660.

DOI: https://doi.org/10.1182/blood-2021-147093

Published: 2021

Journal Articles

Zanubrutinib, Lenalidomide Plus R-CHOP (ZR 2 -CHOP) As the First-Line Treatment for Diffused Large B-Cell Lymphoma (DLBCL)

Huayuan Zhu, Yeqin Sha, Wei Wu, Jingyan Qiu, Yilian Yang, Chen Peng, Chongyang Ding, Zhen Wang, Lei Fan, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 3559.

DOI: https://doi.org/10.1182/blood-2021-150510

Published: 2021

Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updated Long Term Results of Phase II Study

Blood (2021) 138 (Supplement 1): 2638.

DOI: https://doi.org/10.1182/blood-2021-146491

Published: 2021

Journal Articles

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 547.

DOI: https://doi.org/10.1182/blood-2021-152576

Published: 2021

Journal Articles

Intensive Immunosupressive Therapy Combining with Eltrombopag for Adult Chinese Patients with Severe Aplastic Anemia

Ruixin Li, Yuanyuan Jin, Jinsong Jia, Shengyun Lin, Yan Yang, Guangsheng He, Jianyong Li

Blood (2021) 138 (Supplement 1): 2190.

DOI: https://doi.org/10.1182/blood-2021-154361

Published: 2021

Journal Articles

Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial

Kaiyang Ding, Hailing Liu, Haiyan Yang, Lei Cao, Xiaoli Zhao, Wei Wu, Xiaoyan Zhang, Li Wang, Wei Xu, Huayuan Zhu, Jianyong Li, Lei Fan

Blood (2021) 138 (Supplement 1): 1385.

DOI: https://doi.org/10.1182/blood-2021-150145

Published: 2021

Journal Articles

Predictors of Efficacy in Chinese Patients with Severe Aplastic Anemia Treated with Eltrombopag and Intensive Immunosupressive Therapy

Ruixin Li, Guangsheng He, Xi Chen, Zhengyuan Liu, Yan Yang, Shengyun Lin, Jinsong Jia, Yuanyuan Jin, Qiqiang Long, Xiaoqing Liu, Lang Cheng, Jiongtao Zhou, Jianyong Li

Blood (2021) 138 (Supplement 1): 1115.

DOI: https://doi.org/10.1182/blood-2021-152756

Published: 2021

Journal Articles

Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: Cyclophosphamide Responded Better Than Cyclosporine

Xiaoqing Liu, Ruixin Li, Zhengyuan Liu, Jiongtao Zhou, Lang Cheng, Qiqiang Long, Guangsheng He, Jianyong Li

Blood (2021) 138 (Supplement 1): 1120.

DOI: https://doi.org/10.1182/blood-2021-154248

Published: 2021

Journal Articles

Targeting PAK1 Overcomes Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Zijuan Wu, LEI Fan, Luqiao Wang, Hanning Tang, Yi Miao, Wei Xu, Jianyong Li, Hui Jin

Blood (2021) 138 (Supplement 1): 1546.

DOI: https://doi.org/10.1182/blood-2021-150715

Published: 2021

Journal Articles

Functional Evaluation and Mechanism Study of Sting Inhibitor H-151 in Diffuse Large B-Cell Lymphoma

Hui Jin, Luqiao Wang, Zijuan Wu, Xueying Lu, Lei Fan, Danling Gu, Lei Cao, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 2946.

DOI: https://doi.org/10.1182/blood-2021-152180

Published: 2021

2 3 4 5

NARROW

Clinical Significance of Prolymphocytes in Chinese Patients with Chronic Lymphocytic Leukemia

Venetoclax Combined with Dose-Adjusted R-EPOCH (VR-DA-EPOCH) As Treatment of Richter's Syndrome: A Real-World Study

BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia：a Single Arm Real-World Study

The Decrease of Anti-CD3 Antibody Concentration Improved the Cytotoxicity of Chimeric Antigen Receptor (CAR) T Cells in the Treatment of Chronic Lymphoblastic Leukemia (CLL)

Single-Cell Sequencing Technology Reveals the Heterogeneity of the Immune Microenvironment and Key Molecules of Drug Resistance in Angioimmunoblastic T-Cell Lymphoma

Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Single-Cell RNA Sequencing Suggests Novel Drivers of Chronic Lymphocytic Leukemia Patients with Ibrutinib Resistance

The Prognosis of Intermediate- and High-Risk Young AML Patients Who Did Not Receive Allo-HSCT Treated with Intensive Chemotherapy Is Not Superior to That of Elderly AML Patients Treated with the D-CAG Regimen

Investigation of the Heterogeneity Evolution and Drug Resistance Mechanism of Diffuse Large B-Cell Lymphoma Under the Treatment of a Novel HDAC Inhibitor LAQ824

Novel Oncogenic Non-Coding RNA：circRIC8B Regulates Lipid Metabolism Via Mir-199b-5p /LPL Axis in Chronic Lymphocytic Leukemia

Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial

Zanubrutinib, Lenalidomide Plus R-CHOP (ZR 2 -CHOP) As the First-Line Treatment for Diffused Large B-Cell Lymphoma (DLBCL)

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updated Long Term Results of Phase II Study

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Intensive Immunosupressive Therapy Combining with Eltrombopag for Adult Chinese Patients with Severe Aplastic Anemia

Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial

Predictors of Efficacy in Chinese Patients with Severe Aplastic Anemia Treated with Eltrombopag and Intensive Immunosupressive Therapy

Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: Cyclophosphamide Responded Better Than Cyclosporine

Targeting PAK1 Overcomes Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Functional Evaluation and Mechanism Study of Sting Inhibitor H-151 in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only